Home » Authors » Rainer B. Langen

Articles by Rainer B. Langen

MediGene Gains European Rights To Atrix's Leuprogel Product Line

April 11, 2001

By Rainer B. Langen

Cardion Acquires Tolerance For Immunotherapy Platform

April 11, 2001

By Rainer B. Langen

Micromet Raises EUR40M In Fourth Financing Round

April 4, 2001

By Rainer B. Langen

Morphochem Enters Alliances With Aventis Pharma, Sosei

March 28, 2001

By Rainer B. Langen

Schering AG Spins Off Biotech Unit With Funding From Apax

March 21, 2001

By Rainer B. Langen

Germany Grants DM150M For Bioinformatics, Genomics Work

March 14, 2001

By Rainer B. Langen

LION Branching Into Data Area Via Equity Investment In GMD

Feb. 28, 2001

By Rainer B. Langen

G.O.T., atugen Collaborate On Lipids To Knock Down Genes

Feb. 28, 2001

By Rainer B. Langen

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

Feb. 14, 2001

By Rainer B. Langen

GeneScan, Motorola Developing Device For On-Site DNA Analysis

Feb. 7, 2001

By Rainer B. Langen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...